{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T12:23:30Z","timestamp":1787228610901,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T00:00:00Z","timestamp":1782000000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["NSTC 114-2314-B-075 -048"],"award-info":[{"award-number":["NSTC 114-2314-B-075 -048"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["115DHA0100364"],"award-info":[{"award-number":["115DHA0100364"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009096","name":"Taiwan Clinical Oncology Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009096","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031316","name":"Melissa Lee Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.tranon.2026.102876","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T03:13:20Z","timestamp":1782530000000},"page":"102876","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Pan-cancer analysis identifies immunoproteasome as the predominant survival-associated component of antigen processing machinery"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8233-5466","authenticated-orcid":false,"given":"Jiun-I","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Fang","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Cheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Ming","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ta-Chung","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6382","key":"10.1016\/j.tranon.2026.102876_bib0001","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.tranon.2026.102876_bib0002","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s40364-025-00807-w","article-title":"T cells in cancer: mechanistic insights and therapeutic advances","volume":"13","author":"Pu","year":"2025","journal-title":"Biomark. Res."},{"issue":"12","key":"10.1016\/j.tranon.2026.102876_bib0003","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s41571-022-00689-z","article-title":"Clinical implications of T cell exhaustion for cancer immunotherapy","volume":"19","author":"Chow","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.tranon.2026.102876_bib0004","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s40425-019-0647-4","article-title":"Tumor mutational burden quantification from targeted gene panels: major advancements and challenges","volume":"7","author":"Fancello","year":"2019","journal-title":"J. ImmunOther Cancer"},{"issue":"2","key":"10.1016\/j.tranon.2026.102876_bib0005","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1080\/10409238.2019.1610352","article-title":"Structural aspects of chaperone-mediated peptide loading in the MHC-I antigen presentation pathway","volume":"54","author":"Natarajan","year":"2019","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"1","key":"10.1016\/j.tranon.2026.102876_bib0006","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41392-022-01270-x","article-title":"Neoantigens: promising targets for cancer therapy","volume":"8","author":"Xie","year":"2023","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.tranon.2026.102876_bib0007","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41573-021-00387-y","article-title":"Identification of neoantigens for individualised cancer immunotherapy","volume":"21","author":"Lang","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.tranon.2026.102876_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellin.2025.100251","article-title":"Rapid and direct discovery of functional tumor specific neoantigens by high resolution mass spectrometry and novel algorithm prediction","volume":"4","author":"Tian","year":"2025","journal-title":"Cell Insight"},{"issue":"D1","key":"10.1016\/j.tranon.2026.102876_bib0009","doi-asserted-by":"crossref","first-page":"D845","DOI":"10.1093\/nar\/gkac902","article-title":"The Cancer Epitope Database and Analysis resource (CEDAR)","volume":"51","author":"Ko\u015falo\u011flu-Yal\u00e7\u0131n","year":"2023","journal-title":"Nucleic. Acids. Res."},{"key":"10.1016\/j.tranon.2026.102876_bib0010","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13045-025-01732-z","article-title":"The role of neoantigens and tumor mutational burden in cancer immunotherapy: advances, mechanisms, and perspectives","volume":"18","author":"Sun","year":"2025","journal-title":"J. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.tranon.2026.102876_bib0011","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028480","article-title":"Interferon \u03b3 and its important roles in promoting and inhibiting spontaneous and therapeutic cancer immunity","volume":"11","author":"Alspach","year":"2019","journal-title":"Cold. Spring. Harb. Perspect. Biol."},{"issue":"1","key":"10.1016\/j.tranon.2026.102876_bib0012","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0167-4889(97)00152-3","article-title":"Constitutive and interferon-gamma-induced expression of the human proteasome subunit multicatalytic endopeptidase complex-like 1","volume":"1402","author":"Foss","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.tranon.2026.102876_bib0013","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41420-025-02698-0","article-title":"Current landscape of the immunoproteasome: implications for disease and therapy","volume":"11","author":"Zou","year":"2025","journal-title":"Cell Death. Discov."},{"issue":"1","key":"10.1016\/j.tranon.2026.102876_bib0014","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/s41467-020-14639-9","article-title":"Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanoma","volume":"11","author":"Kalaora","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.tranon.2026.102876_bib0015","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1038\/s41598-023-28940-2","article-title":"Increased expression of the immunoproteasome subunits PSMB8 and PSMB9 by cancer cells correlate with better outcomes for triple-negative breast cancers","volume":"13","author":"Geoffroy","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tranon.2026.102876_bib0016","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12967-025-06207-w","article-title":"Immunoproteasome subunits are novel signatures for predicting efficacy of immunotherapy in muscle invasive bladder cancer","volume":"23","author":"Wang","year":"2025","journal-title":"J. Transl. Med."},{"issue":"7403","key":"10.1016\/j.tranon.2026.102876_bib0017","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10983","article-title":"The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups","volume":"486","author":"Curtis","year":"2012","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.tranon.2026.102876_bib0018","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","article-title":"Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer","volume":"173","author":"Hoadley","year":"2018","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.tranon.2026.102876_bib0019","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.cell.2015.09.033","article-title":"Comprehensive molecular portraits of invasive lobular breast cancer","volume":"163","author":"Ciriello","year":"2015","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.tranon.2026.102876_bib0020","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ccell.2018.08.008","article-title":"The genomic landscape of endocrine-resistant advanced breast cancers","volume":"34","author":"Razavi","year":"2018","journal-title":"Cancer Cell"},{"issue":"7643","key":"10.1016\/j.tranon.2026.102876_bib0021","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nature21356","article-title":"Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity","volume":"543","author":"Turner","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.tranon.2026.102876_bib0022","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/s41467-024-45479-6","article-title":"Machine learning-based extrachromosomal DNA identification in large-scale cohorts reveals its clinical implications in cancer","volume":"15","author":"Wang","year":"2024","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.tranon.2026.102876_bib0023","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat. Methods"},{"issue":"7693","key":"10.1016\/j.tranon.2026.102876_bib0024","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.tranon.2026.102876_bib0025","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cell.2016.02.065","article-title":"Genomic and transcriptomic features of response to Anti-PD-1 therapy in metastatic melanoma","volume":"165","author":"Hugo","year":"2016","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.tranon.2026.102876_bib0026","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020107333","article-title":"A single-cell RNA expression atlas of normal, preneoplastic and tumorigenic states in the human breast","volume":"40","author":"Pal","year":"2021","journal-title":"EMBO J."},{"issue":"6282","key":"10.1016\/j.tranon.2026.102876_bib0027","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1126\/science.aad0501","article-title":"Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq","volume":"352","author":"Tirosh","year":"2016","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.tranon.2026.102876_bib0028","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1038\/s41467-020-16164-1","article-title":"Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma","volume":"11","author":"Kim","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.tranon.2026.102876_bib0029","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41392-025-02280-1","article-title":"Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches","volume":"10","author":"Tufail","year":"2025","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"3","key":"10.1016\/j.tranon.2026.102876_bib0030","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/jamaoncol.2021.5970","article-title":"HLA class-I APM upregulation by anti-cancer therapies in the era of checkpoint inhibitors: A review","volume":"8","author":"Sadagopan","year":"2022","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.tranon.2026.102876_bib0031","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s40364-025-00808-9","article-title":"Computation strategies and clinical applications in neoantigen discovery towards precision cancer immunotherapy","volume":"13","author":"Wang","year":"2025","journal-title":"Biomark. Res."},{"issue":"D1","key":"10.1016\/j.tranon.2026.102876_bib0032","doi-asserted-by":"crossref","first-page":"D436","DOI":"10.1093\/nar\/gkae1092","article-title":"The Immune Epitope Database (IEDB): 2024 update","volume":"53","author":"Vita","year":"2025","journal-title":"Nucleic. Acids. Res."},{"issue":"5","key":"10.1016\/j.tranon.2026.102876_bib0033","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s43018-021-00210-y","article-title":"Targeting public neoantigens for cancer immunotherapy","volume":"2","author":"Pearlman","year":"2021","journal-title":"Nat. Cancer"},{"issue":"1","key":"10.1016\/j.tranon.2026.102876_bib0034","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cmp.2025.06.002","article-title":"Intra-tumor DKK1 and CALML5 heterogeneity as a novel biomarker for prognosis and immunotherapy response in head and neck squamous cell carcinoma","volume":"18","author":"Li","year":"2025","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.tranon.2026.102876_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106222","article-title":"Prognostic biomarker MITD1 and its correlation with immune infiltrates in hepatocellular carcinoma (HCC)","volume":"81","author":"Shen","year":"2020","journal-title":"Int. Immunopharmacol."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326002135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326002135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T11:23:59Z","timestamp":1787225039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326002135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":35,"alternative-id":["S1936523326002135"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102876","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pan-cancer analysis identifies immunoproteasome as the predominant survival-associated component of antigen processing machinery","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102876","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102876"}}